Boca Raton, Florida, October 14th, 2026, FinanceWire Collaboration combines INmune Bio’s clinical research with QCi’s Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro Initial engagement marks QCi’s first commercial customer in pharmaceutical and biotechnology markets,…

Boca Raton, Florida, October 14th, 2026, FinanceWire Collaboration combines INmune Bio’s clinical research with QCi’s Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro Initial engagement marks QCi’s first commercial customer in pharmaceutical and biotechnology markets,…